Cancer Treatment: Adding Epratuzumab To Standard Chemotherapy Looks Promising
Friday, May 16, 2008 - 10:21
in Health & Medicine
Adding a second monoclonal antibody drug to chemotherapy looks promising for treatment of diffuse large B-cell lymphoma, according to researchers working with the North Central Cancer Treatment Group.